Sheller PC Wants 3rd. Circ. To Rehear Risperdal Row
Sheller PC has asked the full Third Circuit to review its earlier decision that the Philadelphia-based firm couldn't prove the U.S. Food and Drug Administration's refusal to disavow the antipsychotic drug...To view the full article, register now.
Already a subscriber? Click here to view full article